Back to top
more

Agilent Technologies (A)

(Real Time Quote from BATS)

$141.44 USD

141.44
101,607

-1.48 (-1.04%)

Updated Sep 3, 2024 10:14 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (96 out of 251)

Industry: Electronics - Testing Equipment

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.

Why the Earnings Surprise Streak Could Continue for Agilent (A)

by Zacks Equity Research

Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

In the latest trading session, Agilent Technologies (A) closed at $155.26, marking a -1.85% move from the previous day.

NXP (NXPI) to Report Q3 Earnings: What's in the Offing?

by Zacks Equity Research

NXP Semiconductors' (NXPI) Q3 results are likely to benefit from robust products, strong customer demand and design win momentum.

Waters (WAT) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Waters' (WAT) third-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.

Should Schwab U.S. LargeCap ETF (SCHX) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SCHX

Should Schwab Fundamental U.S. Large Company Index ETF (FNDX) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNDX

Sweta Killa headshot

ETFs to Ride on a Solid Start to Q3 Earnings

by Sweta Killa

The rounds of upbeat earnings has set the stage for the S&P 500 Index to hit new highs as more Q3 earnings unfold.

Sweta Killa headshot

5 Best Performing Stocks of the S&P 500 ETF Last Week

by Sweta Killa

The S&P 500 Index wrapped up its best week since July, climbing 1.8% on encouraging quarterly earnings releases from several companies

Is Schwab Fundamental U.S. Broad Market Index ETF (FNDB) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FNDB

Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FTCS

Should Schwab 1000 Index ETF (SCHK) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for SCHK

Here's Why You Should Hold on to Illumina (ILMN) for Now

by Zacks Equity Research

Investors are optimistic about Illumina (ILMN) owing to its strategic partnerships and wider market adoption of its products.

Is First Trust Capital Strength ETF (FTCS) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FTCS

New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Agilent (A) Up 6.6% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Agilent (A), Visiopharm Unite for Supply of Pathology Solutions

by Zacks Equity Research

Agilent (A) signs an agreement with Visiopharm to globally distribute their pathology solutions.

Has Agilent Technologies (A) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Is (A) Outperforming Other Computer and Technology Stocks This Year?

Agilent Technologies (A) Boasts Earnings & Price Momentum: Should You Buy?

by Zacks Equity Research

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

Agilent (A) Boosts PD-L1 IHC 22C3 pharmDX Assay Use in Europe

by Zacks Equity Research

Agilent Technologies (A) boosts presence in the companion diagnostics market by expanding the use of PD-L1 IHC 22C3 pharmDx assay for esophageal cancer treatment in Europe.

Agilent (A) Q3 Earnings & Revenues Beat Estimates, Rise Y/Y

by Zacks Equity Research

Agilent's (A) fiscal third-quarter results benefit from strength across all geographical regions, business groups and end-market momentum.

Agilent Technologies (A) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Agilent (A) delivered earnings and revenue surprises of 11.11% and 3.67%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?

Factors to Note Ahead of Keysight's (KEYS) Q3 Earnings Release

by Zacks Equity Research

Keysight's (KEYS) Q3 performance is likely to gain from higher demand for its solutions in semiconductor, automotive and aerospace & defense verticals.

What to Expect Ahead of Cisco's (CSCO) Q4 Earnings Release?

by Zacks Equity Research

Cisco's (CSCO) Q4 performance is likely to reflect gains from growing clout of security solutions, Webex and solid Catalyst 9000K adoption.

Agilent (A) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

Agilent's (A) fiscal third-quarter results are likely to reflect strength across its segments and product portfolio.

Why Agilent Technologies (A) is a Top Stock for the Long-Term

by Zacks Equity Research

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.